Return to homepagePandemic Pact

Understanding animal health threats from emerging H5 high pathogenicity avian influenza viruses

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:9 publications

Grant number: BB/X006166/1

Grant search

Key facts

  • Disease

    Influenza caused by Influenza A virus subtype H5, Other

  • Start & end year

    2022
    2023

  • Known Financial Commitments (USD)

    $410,229.34

  • Funder

    UK Research and Innovation (UKRI)

  • Principal Investigator

    Munir Iqbal

  • Research Location

    United Kingdom

  • Lead Research Institution

    The Pirbright Institute

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen genomics, mutations and adaptations

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.

Publicationslinked via Europe PMC

Last Updated:38 minutes ago

View all publications at Europe PMC

The haemagglutinin gene of bovine-origin H5N1 influenza viruses currently retains receptor-binding and pH-fusion characteristics of avian host phenotype.

Pasteurisation temperatures effectively inactivate influenza A viruses in milk.

Immunisation of chickens with inactivated and/or infectious H9N2 avian influenza virus leads to differential immune B cell repertoire development

The Influenza A Virus Replication Cycle: A Comprehensive Review.

Recombinant A(H6N1)-H274Y avian influenza virus with dual drug resistance does not require permissive mutations to retain the replicative fitness in vitro and in ovo.

Characterization of the haemagglutinin properties of the H5N1 avian influenza virus that caused human infections in Cambodia.

Risk assessment of the newly emerged H7N9 avian influenza viruses.

Investigation of H9N2 avian influenza immune escape mutant that lacks haemagglutination activity

Risk Assessment of the newly emerged H7N9 avian influenza viruses